-
October 30, 2017 Lupin Quarter II, FY2018 – Results
-
October 26, 2017 Lupin receives FDA approval for generic Kapvay® Extended-Release Tablets
-
October 25, 2017 Lupin receives FDA approval for generic Axiron® topical solution
-
October 24, 2017 Lupin receives FDA approval for generic Lodosyn® tablets
-
October 11, 2017 Lupin Acquires Symbiomix Therapeutics LLC
-
October 10, 2017 Lupin launches generic Norco® tablets in the US
-
October 9, 2017 Lupin receives FDA approval for generic Corgard® Tablets
-
September 29, 2017 Lupin receives FDA approval for generic Acticlate® Tablets
-
September 25, 2017 Lupin receives FDA approval for generic Clobex® Lotion
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications